$8.28 -0.13 (-1.55%)
11/27/2009 9:45 AM

NeurogesX, Inc. (NGSX)

CAPS Rating: 2 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.

Featured Broker Partners